Skip to main content
Join to View Full Profile
  • 3860 W Ogden AveChicago, IL 60623

  • Phone+1 872-588-3000

Ying Mei, PA is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

Grant Support

  • Silicon nanowire engineered human isogenic cardiac organoids for heart repairCLEMSON UNIVERSITY2024–2028
  • Nanowired hypoimmunogenic hPSC cardiac organoids for heart repairCLEMSON UNIVERSITY2024–2028
  • Silicon nanowire engineered human isogenic cardiac organoids for heart repairCLEMSON UNIVERSITY2024–2028
  • Silicon nanowire engineered human isogenic cardiac organoids for heart repairCLEMSON UNIVERSITY2024–2028
  • Silicon nanowire engineered human isogenic cardiac organoids for heart repairCLEMSON UNIVERSITY2024–2028
  • Silicon nanowire engineered human isogenic cardiac organoids for heart repairCLEMSON UNIVERSITY2024–2028
  • Silicon nanowire engineered human isogenic cardiac organoids for heart repairCLEMSON UNIVERSITY2024–2028
  • Silicon nanowire engineered human isogenic cardiac organoids for heart repairCLEMSON UNIVERSITY2024–2028
  • Nanowired humam cardiac organoid derived exosomes for heart repairCLEMSON UNIVERSITY2023–2027
  • Nanowired human isogenic cardiac organoids to treat acute myocardial ischemia/reperfusion injuriesCLEMSON UNIVERSITY2023–2025
  • Human organoid model for COVID-19 myocarditisCLEMSON UNIVERSITY2023–2025
  • Nanowired human isogenic cardiac organoids to treat acute myocardial ischemia/reperfusion injuriesCLEMSON UNIVERSITY2023–2025
  • Human organoid model for COVID-19 myocarditisCLEMSON UNIVERSITY2023–2025
  • Nanowired human isogenic cardiac organoids to treat acute myocardial ischemia/reperfusion injuriesCLEMSON UNIVERSITY2023–2025
  • Nanowired human isogenic cardiac organoids to treat acute myocardial ischemia/reperfusion injuriesCLEMSON UNIVERSITY2023–2025
  • Human organoid model for COVID-19 myocarditisCLEMSON UNIVERSITY2023–2025
  • Human organoid model for COVID-19 myocarditisCLEMSON UNIVERSITY2023–2025
  • Human organoid model for COVID-19 myocarditisCLEMSON UNIVERSITY2023–2025
  • Human organoid model for COVID-19 myocarditisCLEMSON UNIVERSITY2023–2025
  • Human organoid model for COVID-19 myocarditisCLEMSON UNIVERSITY2023–2025

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence: